http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories
-
How HealthCare Industry is Leveraging Artificial Intelligence to Revolutionize Diagnostics and Early Disease Detection
-
Why Healthcare Providers Are Increasingly Trusting Artificial Intelligence for Detection & Diagnosis
-
Global Medical Service Robotics Market Project to Exceed $20 Billion in 2024 with Additional Growth Expected
-
Artificial Intelligence (AI) Reshaping Healthcare Industry with Unimaginable Potential
-
Medtronic chairman and CEO Geoff Martha to speak at Goldman Sachs global healthcare conference
-
Medtronic to announce financial results for its fourth quarter and full fiscal year 2024
-
Medtronic (MDT) unveils the future of AI in GI: Genius Summit 2024 reveals innovations and collaborations that advance endoscopic care
-
Medtronic unveils the future of AI in GI: Genius Summit 2024 reveals innovations and collaborations that advance endoscopic care
-
Increased Adoption of Artificial Intelligence Across the Healthcare Industry Driving Strong Market Growth
-
Medtronic EVP & CFO Karen Parkhill to participate in the Barclays healthcare conference
-
Medtronic (MDT) Files ITC Action Against Axonics to Stop Use of Medtronic Innovations
-
Medtronic files ITC action against Axonics to stop unauthorized use of Medtronic innovations
-
Medtronic to announce financial results for its third quarter of fiscal year 2024
-
Medtronic LABS President Ruchika Singhal Named “Corporate Social Innovator of the Year” by Schwab Foundation
-
Orchestra BioMed Announces Initiation of BACKBEAT Pivotal Study of AVIM Therapy in Hypertensive Pacemaker Patients
-
Medtronic (MDT) announces approval for MiniMed 780G System with Simplera Sync disposable
-
Medtronic Diabetes announces world's first approval for MiniMed™ 780G System with Simplera Sync™ disposable, all-in-one sensor
-
Hypertension Control Program Aims to Tackle Major Driver of Health Disparities for Black Americans
-
Medtronic Chairman and CEO Geoff Martha to speak at J.P. Morgan healthcare conference
-
Medtronic (MDT) and Cosmo to Expand AI Partnership
-
Cosmo Pharmaceuticals and Medtronic Forge Ahead in AI-Driven Care
-
Medtronic and Cosmo Pharmaceuticals forge ahead in AI-driven care
-
Medtronic announces cash dividend for third quarter of fiscal year 2024
-
Medtronic reports second quarter fiscal 2024 financial results
-
Medtronic (MDT) Announces FDA Approval of Minimally Invasive Device to Treat Hypertension
-
Medtronic announces FDA approval of minimally invasive device to treat hypertension
-
Medtronic: A Majority of Americans Are Optimistic That AI Will Improve Healthcare in 2024
-
A majority of Americans are optimistic that AI will improve healthcare in 2024
-
Medtronic to announce financial results for its second quarter of fiscal year 2024
-
Medtronic Evolut™ TAVR platform outperforms surgery with sustained valve performance for low-risk patients at four years
-
Medtronic (MDT) receives FDA approval for extravascular defibrillator to treat abnormal heart rhythms, sudden cardiac arrest
-
Medtronic receives FDA approval for extravascular defibrillator to treat abnormal heart rhythms, sudden cardiac arrest
-
Medtronic Named to 100 Best Corporate Citizens of 2023
-
TMCF and Medtronic Partner To Launch Academic R&D Grants at HBCUs
-
Medtronic (MDT) announces CE Mark for new Simplera CGM with disposable all-in-one design
-
Medtronic Diabetes announces CE Mark for new Simplera™ CGM with disposable all-in-one design
-
Orchestra BioMed Granted FDA Approval of IDE to Initiate BACKBEAT Pivotal Study of BackBeat CNT™ for the Treatment of Hypertension in Pacemaker Patients
-
Medtronic (MDT) receives CE Mark approval for Inceptiv spinal cord stimulator with closed-loop sensing to treat chronic pain
-
Medtronic receives CE Mark approval for Inceptiv™ spinal cord stimulator with closed-loop sensing to treat chronic pain
-
Medtronic issues statement on the FDA Circulatory Systems Devices Advisory Panel vote for the Symplicity Spyral Renal Denervation System
-
Medtronic to participate in upcoming investor conferences
-
Medtronic reports first quarter fiscal 2024 financial results
-
Medtronic announces cash dividend for second quarter of fiscal year 2024
-
Medtronic to announce financial results for its first quarter of fiscal year 2024
-
Medtronic (MDT) names Greg Lewis to board
-
Medtronic Board appoints Greg Lewis as new Director
-
Medtronic presents new data on MiniMed™ 780G system on fixed meal dosing and real-world Time in Range across wide variety of users
-
Medtronic to present new data on its intelligent dosing platforms at the American Diabetes Association 83rd Scientific Sessions
-
Medtronic (MDT) Appoints Ken Washington as Chief Technology and Innovation Officer
-
Medtronic names Ken Washington new Chief Technology and Innovation Officer

